Author： Bannwarth Bernard Richez Christophe
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.10, Iss.1, 2011-01, pp. : 123-131
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tocilizumab an exciting OPTION in rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. :
Access to resources
Recommend
Tocilizumab top of the class in rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. :
Moving TOWARD tocilizumab for rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. :
Tocilizumab radiates success in rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. :
Tocilizumab: A Review of its Use in the Management of Rheumatoid Arthritis
By Oldfield Vicki Dhillon Sohita Plosker Greg L.
Drugs, Vol. 69, Iss. 5, 2009-03 ,pp. :